Bank of America
FLGT icon

Bank of America’s Fulgent Genetics FLGT Stock Holding History

Bank of America’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.92M Sell
120,583
-32,319
-21% -$701K ﹤0.01% 4144
2025
Q4 		$4.02M Sell
152,902
-3,349
-2% -$86.9K ﹤0.01% 3555
2025
Q3 		$3.53M Buy
156,251
+63,626
+69% +$1.31M ﹤0.01% 4341
2025
Q2 		$1.84M Sell
92,625
-51,452
-36% -$1M ﹤0.01% 4850
2025
Q1 		$2.43M Buy
144,077
+64,016
+80% +$1.09M ﹤0.01% 4503
2024
Q4 		$1.48M Sell
80,061
-57,224
-42% -$1.12M ﹤0.01% 4703
2024
Q3 		$2.98M Buy
137,285
+6,626
+5% +$148K ﹤0.01% 4218
2024
Q2 		$2.56M Sell
130,659
-36,931
-22% -$771K ﹤0.01% 4238
2024
Q1 		$3.64M Buy
167,590
+63,877
+62% +$1.59M ﹤0.01% 3925
2023
Q4 		$3M Buy
103,713
+42,910
+71% +$1.15M ﹤0.01% 4002
2023
Q3 		$1.63M Sell
60,803
-37,643
-38% -$1.29M ﹤0.01% 4457
2023
Q2 		$3.65M Sell
98,446
-32,828
-25% -$1.14M ﹤0.01% 3688
2023
Q1 		$4.1M Buy
131,274
+88,160
+204% +$2.84M ﹤0.01% 3706
2022
Q4 		$1.28M Buy
43,114
+21,164
+96% +$757K ﹤0.01% 4638
2022
Q3 		$837K Buy
21,950
+345
+2% +$17.3K ﹤0.01% 5011
2022
Q2 		$1.18M Sell
21,605
-23,440
-52% -$1.29M ﹤0.01% 4773
2022
Q1 		$2.81M Buy
45,045
+17,767
+65% +$1.17M ﹤0.01% 4239
2021
Q4 		$2.74M Sell
27,278
-2,267
-8% -$199K ﹤0.01% 4247
2021
Q3 		$2.66M Sell
29,545
-143
-0.5% -$13K ﹤0.01% 4177
2021
Q2 		$2.74M Sell
29,688
-15,393
-34% -$1.23M ﹤0.01% 4064
2021
Q1 		$4.36M Buy
45,081
+29,973
+198% +$3.09M ﹤0.01% 3540
2020
Q4 		$787K Buy
15,108
+3,865
+34% +$162K ﹤0.01% 4686
2020
Q3 		$450K Sell
11,243
-109
-1% -$3.41K ﹤0.01% 4791
2020
Q2 		$182K Buy
11,352
+3,451
+44% +$52.8K ﹤0.01% 5312
2020
Q1 		$86K Buy
+7,901
New +$110K ﹤0.01% 5604
2017
Q4 		– Sell
-515
Closed -$2K – 7090
2017
Q3 		$2K Sell
515
-773
-60% -$4.45K ﹤0.01% 6858
2017
Q2 		$8K Buy
1,288
+602
+88% +$4.85K ﹤0.01% 6486
2017
Q1 		$7K Buy
686
+154
+29% +$1.82K ﹤0.01% 6612
2016
Q4 		$6K Buy
+532
New +$5.02K ﹤0.01% 6660

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America's FLGT Position: Q1 2026 in Review

Bank of America reduced its Fulgent Genetics (FLGT) stake by 21% in Q1 2026, selling an estimated $701K and leaving 120,583 shares worth $1.92M. The position accounts for ﹤0.01% of the portfolio, ranked #4144.

Bank of America first reported a position in FLGT in Q4 2016 and has held it in 29 quarters since. The position peaked at $4.36M in Q1 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Bank of America held 120,583 shares of Fulgent Genetics worth $1.92M as of Q1 2026.
  • Bank of America sold 32,319 Fulgent Genetics shares in Q1 2026, an estimated $701K.
  • Fulgent Genetics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4144 holding.
  • Bank of America first reported a position in Fulgent Genetics in Q4 2016 and has held it in 29 quarters since.
  • Bank of America's Fulgent Genetics position peaked at $4.36M in Q1 2021.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.